Introduction to Enterprise Exhibitors

Taiji Group Co., Ltd. was founded in 1972 and completed its strategic restructuring in 2021 to become a holding enterprise of China National Pharmaceutical Group Co., Ltd. (Sinopharm).

Focusing primarily on modern intelligent manufacturing of traditional Chinese medicine (TCM) with complementary specialization in narcotic and psychotropic chemical drugs, Taiji Group serves as a key component of Sinopharm's modern TCM business segment, dedicated to inheriting and innovating TCM while developing modern pharmaceuticals. The group comprises one listed company (Taiji Group, stock code: 600129), 13 manufacturing plants, over 20 pharmaceutical commercial companies, and two major retail pharmacy chains - "Tongjunge Pharmacy" and "Taiji Pharmacy". Its business spans pharmaceutical R&D, industrial production, commercial distribution, Chinese herbal medicine resources, and health industry sectors, with a total of 1,240 drug approvals and 12,000 employees.

Exhibits